Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?
- PMID: 33895812
- PMCID: PMC8135491
- DOI: 10.1093/rheumatology/keab386
Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?
Comment on
-
Baricitinib set to join the Covid-19 therapeutic arsenal?Rheumatology (Oxford). 2021 Apr 6;60(4):1585-1587. doi: 10.1093/rheumatology/keab061. Rheumatology (Oxford). 2021. PMID: 33502499 Free PMC article. No abstract available.
References
-
- Wilcox RA. Janus family kinase (JAK) inhibitors in HLH and severe COVID-19. Am J Hematol 2020;95:1448–51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources